Michigan Farmers Harvest First Technical Cannabis Harvest

Following the adoption of the Farming Act in 2018, which legalized technical cannabis varieties, cannabis was sown in Michigan. On October 8, local farmers harvested their first crop and reported on the results of the 2019 harvesting campaign.

Hemp is more profitable to grow than other crops

Michigan authorities issued 572 licenses for the cultivation of cannabis on a total area of ​​13,198 hectares, 423 enterprises received permission to process the plant. Hemp was planted in the spring and summer of this year, so not all farmers have harvested yet. The director of the cannabis growing program, Gina Allessandry, said that information on the volume of production of hemp products will be known at the end of the year.

Local farmer David Connor decided to grow hemp instead of blueberries. This year he collected 9 tons of raw materials from an area of ​​10.5 hectares. CBD will be extracted from cannabis inflorescences, the stems will go to the production of building materials, paper and fabric. Conor argues that hemp is more profitable to grow than all other crops. For example, a blueberry crop harvested from 0.4 hectares costs $ 543, and cannabis yield from the same area ranges from $ 10,000 to $ 12,000.

CBD market continues to grow

Farmers get the lion’s share of the profits from the CBD market. The cannabinoid is added to the oil, tinctures, creams, food, and even animal feed. According to economists, the volume of trade in cannabidiol products in the United States will reach 22 billion by 2022. The popularity of a substance among consumers is due to its versatility: CBD is used to treat various diseases, for cosmetic purposes and as a bioactive additive.

Gary Schuler, the founder of GTF LLC in Michigan, believes that the main advantage of cannabis is that it can be used in its entirety. GTF LLC dries and processes cannabis waste. From the obtained raw materials produce food products, biodegradable plastic, and building materials.

The Michigan government plans to continue implementing an industrial hemp cultivation program next year. The authorities are ready to issue licenses for growing and processing plants to all interested institutions. In addition, on November 1, the administration will start accepting applications from companies that want to work in the recreational cannabis market. The first hemp stores will be open in 2020.

In Thailand, a new variety of marijuana

The variety is called Issara 01, which translates from Thai as “freedom.”

Varieties of marijuana often come up with colorful and funny names, sometimes forgetting that this plant not only enhances mood. For some, including the Thai government, cannabis is still medicine. And medicines often give freedom to chronically ill people.

Last week, scientists at Maejo University in Chiang Mai announced that they introduced a new cannabis variety specifically for the state medical marijuana program. To obtain it, the local variety was crossed with a northern foreign one and named it Issara 01, which translates as “freedom” or “independence”.

Issara 01 has the same amount of THC and CBD. In the United States, cannabidiol has become popular as a non-intoxicating “cure for all diseases,” and it does have anti-inflammatory and anticonvulsant properties. THC, which affects the cognitive abilities of patients, has the same medical benefits as CBD. According to research, CBD is most effective together with THC, which is why the Thai government called for a state variable with the same content of both components.

Now Thai medical marijuana is not distributed in the form of jambs or deb. From it makes a thick, crude oil, which is issued only to chronically or seriously ill patients in public hospitals. Thailand’s medical marijuana program was far ahead of similar programs in other countries, such as the United States and the United Kingdom, where hospital staff cannot prescribe most cannabis-based medicines. Nevertheless, the country lags behind in other aspects, as can be seen from the temporary ban on home cultivation of hemp. However, the state will further allow this, if the medical marijuana program is successful and nothing unexpected happens.

“These are historical events: the first steps to allowing everyone to grow up to six cannabis bushes,” said Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul. “The university will become a center where ordinary people can learn how to plant and to grow quality cannabis. Cannabis is not a political issue, but a product that can have a beneficial effect on people’s health. In the near future, families will be able to plant it in the backyard like any other herbs. “

Cannabis cultivation complex at Maejo University – the largest in Thailand. Its area covers a little more than 12 km2, and 12,000 bushes of medical hemp grow on the territory. It is expected that it will yield a crop of about 2.6 tons. The university is currently working on a new species, Maejo 01, based solely on local varieties.

“If the plantation license is approved, we plan to expand the area for hemp cultivation. Most likely, the soil is suitable for all local varieties that can be found in many parts of the country,” said Arnat Tancho, director of the agricultural research center at Maejo University. “We also we’ll continue to analyze and select the most suitable varieties for specific medical tasks. “

Why the US authorities do not want to legalize hemp

Medical or recreational cannabis is legalized in 33 US states (out of 51, including the District of Columbia). However, at the federal level, the plant remains illegal. What are the causes of this paradoxical phenomenon?

A record number of Americans support the legalization of cannabis

In October 2018, the number of supporters of hemp legalization reached a historic high. Surveys conducted by Gallup, Pew Research Center, CBS News, and Quinnipiac University have lifted the ban on plants from 60% to 66% of U.S. residents. However, cannabis is on Schedule I of narcotic substances that do not have medical value. If most Americans favor reform of the law, then why do government officials representing the will of the people not want to remove or soften the rules governing cannabinoid trafficking?

The budget will lose money due to the legalization of hemp

According to the Tax Code, hemp enterprises have an increased income tax rate (from 70% to 90%), since they are not included in the list of corporate institutions due to illegal status at the federal level. If the ban on the plant is lifted, then the cannabis industry will become a normal business area, and its representatives will have the opportunity to take advantage of tax deductions. It will cost the federal budget about $ 5 billion over the next 10 years.

Republicans oppose lifting the ban on cannabis

Most seats in the Senate are controlled by the Republican Party, led by Mitch McConnell, who thwarts attempts by other senators to submit cannabis laws to legislators. For example, last December, McConnell refused Corey Gardner to amend the Criminal Justice Reform Act to protect the states from federal interference.

Legalization of hemp is not a priority

The attention of US senators is focused on solving more important problems than the legalization of cannabinoids. The reform of the cannabis law is one of the last places on the list of tasks since lifting the ban will not have a significant impact on the country’s economy. In addition, marijuana is not the reason for the polarization of society, because only one out of eight voters will vote for another candidate for the post of a senator, if their opinions on cannabis do not coincide. Thus, officials are not afraid of losing their posts due to disagreements with the electorate over hemp.

Government fears for safe public health

Last week, the Centers for Disease Control said 12 people died of viper disease, and 805 Americans were hospitalized. In many cases, patients used liquids for vaporizers with THC, so the authorities blame the hemp industry for the epidemic. Certainly, cannabinoids are much safer for health than many other narcotic substances, moreover, they can be used as an alternative to opiates, which caused the death of more than 47,000 Americans in 2018. But due to the lack of scientific data, authorities fear that the legalization of hemp can harm the well-being of citizens in the long run.

Cannabidiol twice cheaper in a year

The adoption of the Farming Act in the United States in December 2018, which legalized technical hemp at the federal level, had a significant impact on the cannabis industry. Due to the increase in the area under crops, a sharp drop in the price of cannabidiol is observed.

A kilogram of CBD costs $ 4,133

In the period from October 2018 to August 2019, the price of pure CBD decreased by 56% (from 9,740 to 4,133 dollars per kilogram). Experts attribute the negative trend to the development of hemp breeding in the United States. According to a Hemp Gazette report, this year the area of ​​hemp farmland increased by 455% and reached 206,390 hectares. In practice, however, cannabis was only sown on 93,000 hectares.

Kush.com portal director Chase Nobles predicts a collapse in the cost of cannabinoids in the global market due to an increase in the number of cannabis growing and processing enterprises. If all American farmers who have received a license for plant cultivation plant cannabis, then the cultivated area will almost double (compared to the current figure), which will lead to a significant increase in the volume of production of raw materials.

The situation in the American hemp market will affect the European industry

According to experts, this year the volume of cannabidiol products in the United States will reach 4,700 tons, which is eight times higher than the demand. Therefore, economists predict a decrease in the cost of raw materials and, as a result, a five-fold drop in the yield of cannabis cultivation (from $ 50,000 to $ 10,000 from 0.4 hectares of crops). An oversupply of products in the US market will have a domino effect on the European industry. Between August 2018 and August 2019, the average cost of CBD in Europe almost halved, completely reflecting the dynamics of changes in the price of cannabinoid in the United States.

Technavio conducted a study of the global cannabis market and concluded that a price war broke out between large enterprises in the industry. The reason for this phenomenon was an increase in the difference between supply and demand. The head of one of the European hemp companies said that they have to reduce the cost of CBD every month due to an oversupply of products. Now the price of cannabidiol is in free fall, and experts can not determine to what point cannabinoids will fall in price.

Scientists have developed Escherichia coli, which produces psilocybin

A group of scientists from the University of Miami managed to develop a method for producing psilocybin using bacteria. According to experts, microorganisms produce a substance much faster than fungi and require less area.

Psilocybin production technology on an industrial scale

University staff led by Professor Andrew Jones isolated the nucleotide sequence in the fungal DNA chain responsible for psilocybin synthesis. Then the engineers introduced the fungal genome into the DNA of Escherichia coli, which then began to produce psilocybin, fulfilling the established genetic program.

The second phase of the project was to make the bacterium produce psychedelics in large numbers. To solve this problem, experts conducted experiments for several months and achieved high results. Initially, a 1-liter bacterial colony synthesized several milligrams of psilocybin. Subsequently, this figure increased to 1.16 grams. According to Jones, the productivity of microorganisms has grown 500 times.

Unfortunately, the free version of the research report does not indicate the period for which bacteria produce psilocybin. However, Jones is confident that the technology can be used to produce psychedelics on an industrial scale, as its results are superior to all other methods from an economic point of view.

Psilocybin needed for clinical trials

The authors of the research project noted the medicinal potential of psilocybin, which was confirmed by testing the effectiveness of the substance for the treatment of addiction, depression and post-traumatic stress disorder. However, the US authorities do not recognize the healing properties of mushrooms, so they are in Schedule I of narcotic substances.

Despite officials’ skepticism of psilocybin, several American educational institutions have applied for the study of psychedelics. Among them was the Heffter Research Institute, which set two main tasks for scientists:

  1. learn how psilocybin affects the brain and psyche;
  2. develop ways to alleviate side effects from taking the substance.

Institute President George Greer said that experts plan to evaluate the effectiveness of psilocybin in the fight against various types of addiction and mental disorders caused by cancer. One of the most promising areas is considered psilocybin therapy of cancer patients. Nevertheless, doctors say that psychedelics should be consumed only under the supervision of professionals, as it can cause negative consequences: high blood pressure and arrhythmia. In addition, psilocybin can provoke an attack on people who suffer from psychosis or manic disorders.

Cannabinoid Tips from Hemp CEOs

CEOs of major hemp companies deny the use of cannabis to get rid of the image of drug dealers. However, the directors of several medium-sized enterprises do not hide their love for marijuana and openly talk about how and why they take cannabinoids.

Cannabis against attention deficit disorder

Max Simon, director of California-based Green Flower, uses 3-5 mg of THC every morning before work and takes several microdoses of cannabinoid throughout the day. He uses the substance to treat attention deficit disorder, as traditional drugs do not help cope with the symptoms of the disease. According to Max, TGC helps focus attention. He does not prohibit subordinates from smoking marijuana if this does not prevent them from working.

Cannabinoids as a dietary supplement

The founder of Grasslands, an American company, Ricardo Baca begins the morning with a multicannabinoid complex consisting of a capsule with pure CBD and a tincture that contains several cannabinoids (mainly CBD). Baka perceives hemp as a biologically active food supplement that helps him cope with stress. Thanks to cannabinoids, he was able to reduce the volume of coffee consumption and increase the level of performance. Ricardo does not take THC during work and believes that this substance was created for use in a comfortable home environment. But Baka is always not averse to tasting the products of his clients at the workplace if they insist on it.

Cannabis for Anxiety Disorder

Founder and CEO of Los Angeles-based Apothecary, Whitney Butte, is suffering from an anxiety disorder. To treat the disease, she smokes marijuana with a high concentration of CBD, since a large dose of THC can trigger an anxiety attack. Butti usually uses cannabis before meetings and conferences. On weekdays, Whitney uses CBD fluids for vaporizers. According to her, cannabidiol helps reduce anxiety caused by busy work schedules and traffic jams. In the morning, she adds tincture with CBD and THC to coffee in a ratio of 18: 1.

Marijuana Boosts Creativity

Kikoko co-founder Amanda Jones came up with the concept of a marketing campaign with Sympa-tea, which contains turmeric, ginger, 3 mg THC and 20 mg CBD. Jones saw all the surrounding objects in the yellow spectrum and decided to use this color in product design. In her opinion, 3 mg of THC is the optimal dosage to stimulate creativity. However, during working hours, she does not take more than 1 mg of THC so as not to lose vigilance. Amanda believes that cannabinoid is best consumed in the evening because at this time the substance most liberates the mind. Therefore, most often she takes 6-7 mg of THC at 18:00. To solve production problems, Jones consumes up to 10 mg of THC and then discusses the situation with his business partner Jennifer Chapin.